Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 7/20 | 0.33 |
| ▸ | CASP7 | P55210 | 6/20 | 0.33 |
| ▸ | ARG1 | P05089 | 2/20 | 0.33 |
| ▸ | ARG2 | P78540 | 2/20 | 0.33 |
| ▸ | CASP9 | P55211 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14626426 | 1.00 | HDAC8 (0.37) | HDAC8HDAC6HDAC1DRD2DRD3 | |
| SCHEMBL302348 | 1.00 | HDAC8 (0.37) | HDAC8HDAC6HDAC1DRD2DRD3 | |
| SCHEMBL28462230 | 0.88 | — | — | |
| SCHEMBL22089728 | 0.88 | — | — | |
| SCHEMBL28464919 | 0.88 | — | — | |
| SCHEMBL2203324 | 0.82 | HDAC8 (0.35) | HDAC8HDAC6HDAC1DRD2DRD3 | |
| SCHEMBL16090769 | 0.80 | CASP3 (0.31) | CASP3CASP7 | |
| SCHEMBL6506120 | 0.78 | — | — | |
| SCHEMBL12311430 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL28835154 | 0.76 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111303441-B | Proline and proline derivative functionalized chiral metal organic framework material and synthesis method thereof | 忻州师范学院 | 2021-09-03 | — | — | CN | claimed |
| CN-111303441-A | Proline and proline derivative functionalized chiral metal organic framework material and synthesis method thereof | 忻州师范学院 | 2020-06-19 | — | — | CN | claimed |
| WO-2020119896-A1 | HETEROCYCLIC INHIBITORS OF ATX | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-18 | — | — | WO | claimed |
| US-9944850-B2 | Carbon nanostructure and method for preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-04-17 | — | — | US | claimed |
| US-20170058193-A1 | CARBON NANOSTRUCTURE AND METHOD FOR PREPARING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-03-02 | — | — | US | claimed |
| CN-111704615-B | Imidazo [1,5-A ] pyrazine derivatives as PI3Kdelta inhibitors | 百济神州有限公司 | 2023-02-17 | — | — | CN | disclosed |
| WO-2023006097-A1 | BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER | 海创药业股份有限公司 | 2023-02-02 | — | — | WO | disclosed |
| CN-111303441-B | Proline and proline derivative functionalized chiral metal organic framework material and synthesis method thereof | 忻州师范学院 | 2021-09-03 | — | — | CN | disclosed |
| CN-111704615-A | Imidazo [1,5-A ] pyrazine derivatives as PI3K inhibitors | 百济神州有限公司 | 2020-09-25 | — | — | CN | disclosed |
| CN-111303441-A | Proline and proline derivative functionalized chiral metal organic framework material and synthesis method thereof | 忻州师范学院 | 2020-06-19 | — | — | CN | disclosed |
| CN-111051312-A | Imidazo [1,5-A ] pyrazine derivatives as PI3K delta inhibitors | 百济神州有限公司 | 2020-04-21 | — | — | CN | disclosed |
| US-9944850-B2 | Carbon nanostructure and method for preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-04-17 | — | — | US | disclosed |
| US-6316626-B1 | Amine compounds and combinatorial libraries comprising same | ISIS PHARMACEUTICALS, INC. | 2001-11-13 | — | — | US | disclosed |
| US-6197965-B1 | POLYARYLALKYLAMINO-SUBSTITUED PYRIDINE DERIVATIVES; DRUGS, MEDICINE, DIAGNOSTICS | ISIS PHARMACEUTICALS, INC. | 2001-03-06 | — | — | US | disclosed |
| US-6187928-B1 | TREATING FUNGAL DISEASES | THE ROCKEFELLER UNIVERSITY | 2001-02-13 | — | — | US | disclosed |
| EP-0817787-A4 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS INC (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6087510-A | Method of use of imidazolium cations | THE ROCKEFELLER UNIVERSITY (US) | 2000-07-11 | — | — | US | disclosed |
| US-5874587-A | FLUORESCENCE | THE ROCKEFELLER UNIVERSITY (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |